Maker of first FDA-approved prescription software files for bankruptcy, ousts CEO


Five years after the FDA approved the first-ever prescription software to treat substance use disorder, the company behind the treatment has filed for bankruptcy protection and is on the verge of shutting down.

Previous Opioid settlement backs Meta House plan for $32M residential treatment campus in Glendale
Next New event venue opening soon near downtown St. Paul